Probiotics, live microorganisms beneficial to health, and prebiotics, substances that promote their growth, play a significant role in managing chronic diseases. Probiotics contribute to maintaining gut health by balancing the microbiome, which can impact inflammation and immune function. This balance is crucial in conditions such as irritable bowel syndrome, inflammatory bowel disease, and type 2 diabetes, where gut dysbiosis often exacerbates symptoms. Prebiotics, found in foods like garlic and bananas, serve as fuel for probiotics, enhancing their effectiveness. By improving gut barrier function and reducing systemic inflammation, both probiotics and prebiotics help in managing chronic diseases. Their role extends to influencing metabolic processes and supporting overall immune function, highlighting their potential as complementary interventions in chronic disease management. However, the effectiveness of probiotics can vary, and more research is needed to fully understand their benefits across different conditions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India